Great Point Partners was founded in 2003 with a vision of helping growing health care companies achieve their full potential.
Since then, we have partnered with innovative executives to build successful health care companies by utilizing both our capital and our industry expertise. Great Point Partners recognizes that there is tremendous synergy gained by investing in both private and public companies across the health care spectrum; therefore we have two distinct teams managing separate, but highly complementary investment strategies – lower middle market growth buyout funds investing in private health care companies and a hedge fund investing in public life sciences companies.
Great Point Partners I (GPP I, $156 million) and Great Point Partners II (GPP II, $215 million) invested in 24 growing and profitable health care companies. We are currently investing from GPP III, a $306 million fund making growth recapitalizations and growth equity investments between $7 and $30 million.
Our public equity fund, the BioMedical Value Fund, is a deep value investment fund investing in small and mid-capitalization, publicly traded biotechnology and life sciences companies that are transforming medicine.